Abstract

RIFLE provides standardized criteria for defining acute kidney injury (AKI) [1]. It is based on changes in serum creatinine (sCr), in relation to a premorbid sCr, and on urine output. When premorbid sCr is unknown, baseline sCr is estimated. Often only sCr is used (RIFLEcreat). Thus there are four methods for defining AKI: actual RIFLE, actual RIFLEcreat, estimated RIFLE and estimated RIFLEcreat. There is much interest for biomarkers predicting early AKI [2]. Critical for determining a biomarker's performance of AKI is the diagnosis of the first day of AKI (AKI-0). We compared the impact of four AKI definitions on determining AKI-0.

Highlights

  • In this study we aimed to investigate the relationship between thyroid hormone abnormalities and major cardiovascular events and sudden cardiac death at 3 and 6 months after discharge in patients who were admitted to the Emergency Department with acute coronary syndrome

  • The aim of this study was to demonstrate the role of arginase and adenosine deaminase (ADA) in patients suffering from myocardial infarction (MI), and in a group of patients with chronic renal failure (CRF) with cardiovascular diseases (CVD)

  • ADA may be considered good diagnostic enzymes in patients suffering from MI, and ADA for patients with CRF with CVD

Read more

Summary

Introduction

Results We studied 53 patients (42 males, mean age (SEM) 57.6 (2.8) years, illness severity scores APACHE II 21.3 (0.9); SAPS II 53.3 (2.3); SOFA 10.2 (0.2); and ICU stay 35.9 (4.8) days). Results We included 53 consecutive patients (42 males, mean age 57.6 ± 2.8 years, illness severity scores APACHE II 21.3 ± 0.9; SAPS II 53.3 ± 2.3; SOFA 10.2 ± 0.2; and mean ICU stay 35.9 ± 4.8 days) of which 25 (47.2%) had at least one US findings. The objective of this study was to determine the incidence and type of incidents related to intrahospital transport (IHT) of critically ill patients in our ICU and to identify contributing factors of these incidents. The aim of this study was to assess the effect of monotherapy with nebulized colistin on clinical and microbiological outcomes in critically ill patients with VAT due to polymyxin-only susceptible Gram-negative bacteria

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call